Celebrating the Lynn Sage Foundation’s Generous Support of Breast Cancer Research at Northwestern | Dr. Steve T. Rosen, Dr. Virginia G. Kaklamani, and
representatives from the Lynn Sage Foundation (r to l) |
Donations to the Robert H. Lurie Comprehensive Cancer Center of Northwestern University advance many things. For the Lynn Sage Foundation, their contributions advance hope. By furthering breast cancer research through the Lynn Sage Scholars program, they not only are creating new medical knowledge, but also hope for current and future cancer patients and their families. On Wednesday, February 17, the Lynn Sage Foundation, represented by Laura Sage and family, joined Dr. Steve T. Rosen, director of the Lurie Cancer Center, to present and celebrate the Foundation’s most recent donation in support of breast cancer research at Northwestern University Feinberg School of Medicine. Established by Yale Sage and his daughters, Halee and Laura, in memory of their wife and mother, the Foundation is committed to the discovery of a cure for breast cancer. Most recently, they launched a Mother's Day campaign to celebrate and recognize all mothers. For all donations of $25 or more, the Foundation will send an eCard that wishes special someone a Happy Mother's Day and informs her that a donation has been made in her honor to help find a cure for breast cancer. To support this Mother's Day campaign, visit: https://www.lynnsagefoundation.org/SubmitDonation.aspx. After a short meet-and-greet, Dr. Rosen extended his sincere thanks for the Foundation’s ongoing support of the work of Northwestern’s talented researchers, highlighting the efforts of Dr. Virginia G. Kaklamani, the current Lynn Sage Scholar. Excitedly expressing her gratitude, Dr. Kaklamani led the guests on a tour of her laboratory. On the lab tour, Dr. Kaklamani described her work, and discussed the benefits of genetic testing in the prevention and early detection of breast and ovarian cancers. In particular, she spoke on one of her research studies that profiled the genetic material of breast and ovarian cancer patients at the Lurie Cancer Center, looking for patterns and commonalities that may indicate an increased risk for these diseases. Dr. Kaklamani’s discussion led to questions regarding popular genetic tests currently recommended, including BRACanalysis. Dr. Kaklamani carefully explained the benefits of these tests, detailing both their importance and clarifying misleading hearsay. The guests from the Foundation thanked Dr. Kaklamani for her forthright and intelligent responses, and expressed their pride in funding her work that will certainly make a difference in efforts to prevent and treat cancer. By: Andrea Arntsen-Harris | 
